About PQ Bypass
PQ Bypass is a company based in Mountain View (United States) founded in 2011 was acquired by Endologix in April 2021. PQ Bypass has raised $71.67 million across 8 funding rounds from investors including Endologix, Informa Connect and Seroba Lifesciences. The company has 1 employees as of December 31, 2022. PQ Bypass offers products and services including Clinically Integrated Networks and Blockchain Integration. PQ Bypass operates in a competitive market with competitors including Avinger, LeMaitre Vascular, Okami Medical, Cagent Vascular and Pathway Medical Technologies, among others.
- Headquarter Mountain View, United States
- Employees 1 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Pq Bypass, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PQ Bypass
PQ Bypass offers a comprehensive portfolio of products and services, including Clinically Integrated Networks and Blockchain Integration.
System for coordinating patient care among providers
Secure storage and sharing of patient records
Funding Insights of PQ Bypass
PQ Bypass has successfully raised a total of $71.67M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PQ Bypass
PQ Bypass has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Endologix, Informa Connect and Seroba Lifesciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Offers live events, digital content, training courses for industry professionals worldwide.
|
Locked | Locked | Locked |
Investor details for PQ Bypass
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PQ Bypass
Investment portfolio details for PQ Bypass
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PQ Bypass
Detailed financials for PQ Bypass
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pq Bypass Comparisons
Peer comparison for PQ Bypass
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PQ Bypass
PQ Bypass operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avinger, LeMaitre Vascular, Okami Medical, Cagent Vascular and Pathway Medical Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of image-guided catheter-based products for peripheral artery disease
|
|
| Locked | Locked | Locked |
Devices for peripheral vascular disease treatment are developed and marketed.
|
|
| Locked | Locked | Locked |
Innovative medical devices for peripheral vessel treatment are developed.
|
|
| Locked | Locked | Locked |
Devices for removing vascular blockages are developed.
|
|
| Locked | Locked | Locked |
Smart devices are provided to clear peripheral arterial blockages.
|
|
| Locked | Locked | Locked |
Implants for repairing arteries after angioplasty are developed.
|
Detailed competitors of PQ Bypass
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pq Bypass
Complete news archive for PQ Bypass
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PQ Bypass
PQ Bypass was founded in 2011 and raised its 1st funding round 1 year after it was founded.
PQ Bypass is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
PQ Bypass is a funded company, having raised a total of $71.67M across 8 funding rounds to date.
As of Dec 31, 2022, the latest employee count at PQ Bypass is 1.
PQ Bypass was founded in 2011 and is based in Mountain View, United States. Medical devices for a percutaneous femoral artery bypass are provided by the company to address peripheral artery disease. Nearly 500,000 surgical bypasses or lower leg amputations occur worldwide annually for this condition. A CE Mark clinical study has been initiated, with commercialization anticipated in 2017.
PQ Bypass's top competitors include Avinger, Okami Medical and Cagent Vascular.
PQ Bypass offers Clinically Integrated Networks and Blockchain Integration.
PQ Bypass has 5 investors. Key investors include Endologix, Informa Connect, Seroba Lifesciences, Ascent Biomedical Ventures, and Fogarty Institute for Innovation.